Form D — Acurx Pharmaceuticals, Inc.
0001736243-25-000002 · filed 2025-03-21
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $3,376,350
- Total sold
- $3,376,350
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Acurx Pharmaceuticals, Inc.
- CIK
- 1736243
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 259 LIBERTY AVENUE
STATEN ISLAND, NY 10305 - Phone
- 917-533-1469
Related persons
-
David P. Luci · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Robert J. DeLuccia · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Robert G. Shawah · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Jack H. Dean · DirectorStaten Island, NY Find on LinkedIn ↗
-
James Donohue · DirectorStaten Island, NY Find on LinkedIn ↗
-
Thomas Harrison · DirectorStaten Island, NY Find on LinkedIn ↗
-
Carl Sailer · DirectorStaten Island, NY Find on LinkedIn ↗
-
Joseph Scodari · DirectorStaten Island, NY Find on LinkedIn ↗
View original on SEC EDGAR.